Explore News By Topic

08/23/2017

Prostate Cancer Foundation Announces Six 2017 Challenge Awards Funded in Partnership with the Movember Foundation

SANTA MONICA, CA, August 23, 2017 – The Prostate Cancer Foundation (PCF) today announced six new Challenge Awards funded in partnership with the Movember Foundation. These multi-year awards support cross-disciplinary teams of investigators conducting pioneering research to advance treatments and cures for prostate cancer. PCF received a donation of $5.4... Read More

08/10/2017

Statistical Shortcut Could Speed Evaluation of Prostate Cancer Drugs

Clinical trials of adjuvant therapies used in treating some men with prostate cancer could be completed more quickly by using a “surrogate” endpoint, scientists report The investigators found that metastasis-free survival – how long patients survived without the cancer spreading – was a strong predictor of their overall survival BOSTON,... Read More

08/04/2017

Researchers make mathematical crystal ball to gaze into future of prostate cancer treatment

Aurora, CO, August 4, 2017 - The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. These patients may have been better off with another treatment or alternative dosing of docetaxel... Read More

08/02/2017

Comprehensive sequencing program shows promise of precision medicine for advanced cancer

ANN ARBOR, Michigan, August 2, 2017 — The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors... Read More

07/10/2017

Prostate Cancer Foundation Announces 2017 Young Investigator Award Recipients

SANTA MONICA, CA, July 10, 2017 -- The Prostate Cancer Foundation (PCF) today announced its 2017 Young Investigator (YI) Awards, which support early career scientists who are focused on accelerating the delivery of life-extending and life-saving therapies for men living with prostate cancer. The YI Awards provide three years of... Read More

07/07/2017

Precision medicine study finds new treatment for untreatable subtype of advanced prostate cancer

A clinical trial reported on at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that advanced prostate cancer patients whose tumors have a certain combination of mutations may significantly benefit from treatment with platinum chemotherapy. Not all “chemotherapy” is the same.  Taxane chemotherapy (docetaxel, cabazitaxel) which works... Read More

06/29/2017

Combination of two new therapies may be highly effective in advanced prostate cancer

Early results from a clinical trial presented at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that combining an immunotherapy with a targeted therapy may be highly effective in patients with advanced prostate cancer. Checkpoint immunotherapy, a treatment that reboots hibernating tumor-killing immune cells, has produced remarkable,... Read More

06/21/2017

Immunotherapy and Prostate Cancer

Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer Checkpoint Inhibitors Miracle Drugs for Some, But Not Yet All Checkpoint inhibitors have one mission: to wake up the sleeping T cells, and in some people with cancer, they... Read More

06/20/2017

Immunotherapy: Who’s Who in the Immune System

Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer   Making sense of some very complicated stuff only a few scientists truly understand: A guide to the immune system for the rest of us. Let’s think of the... Read More

New three-in-one blood test opens door to precision medicine for prostate cancer

Test picks out men for treatment, detects early signs of resistance and monitors cancer’s evolution over time Advance is part of strategic push to overcome cancer evolution and drug resistance   LONDON, June 18, 2017  - Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate... Read More